Other Product. Acceptance of Product that is not First Order Product shall occur as follows:
Other Product. (a) [ * ].
Other Product. Other Product Commercial Milestone Event [*] Commercial Milestone Payment [*] [*] [*] [*] [*] [*] [*] [*] [*] [*] [*] [*] For clarity, recitations of [*] in the table immediately above refers to [*].
Other Product. “Other Product” shall mean any and all finished drug product formulations containing (i) any Product Candidate which is directed to any target other than HBV and selected by Purchaser pursuant to Section 1.3(a)(ii), or (ii) any derivative or variant or other modification of the foregoing.
Other Product. The term "Other Product" shall mean any Licensed -------------- Product for use in the Field which is not an Antibody Product or a Vaccine Product.
Other Product. Distribution and Networks agree to negotiate in good faith on a product-by-product basis with respect to Networks' licensing pay television exhibition rights to any television product which does not fall under this agreement (i.e., series, documentaries and specials, etc.) and for which Distribution controls such rights during the Term. Networks acknowledges that the project "Tenth Kingdom" is specifically excluded from this agreement.
Other Product. Distribution and Crown Media agree to negotiate in good faith on a product-by-product basis with respect to Crown Media's licensing pay television exhibition rights to any television product which does not fall under this agreement (i.e., series, documentaries and specials, etc.) and for which Distribution controls and Crown Media desires to acquire such rights during the Term. Crown Media acknowledges that the project "Dinotopia" is specifically excluded from this agreement.
Other Product. The term “Other Product” shall mean any product that is not itself a Licensed Product but that:
Other Product. 14 [*] = Certain confidential information contained in this document, marked by brackets, has been omitted because it is both (i) not material and (ii) would likely cause competitive harm to the company if publicly disclosed.
Other Product. 3.1 The Parties agree that each has the right to independently invent, develop, manufacture, market and sell proprietary formulations they have each independently developed within and outside the Field and will retain exclusive worldwide rights to such proprietary formulations (other than the Licensed Products and Improvements).
